Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Or

(904) 244-0411 MyUFHealth Education Research Community

Treats Adults

Francesco Franchi, MD

Cardiologist

Additional languages:: Italian

(904) 383-1011

Request appointment online

Established patients New patients

Research at a glance

Top areas of exploration

Platelet Aggregation Inhibitors , 79 publications
Percutaneous Coronary Intervention , 47 publications
Purinergic P2Y Receptor Antagonists , 41 publications
Clopidogrel , 35 publications

Research activity

128 publications

3,365 citations

Why is this important?

Active clinical trials

Investigator: Francesco Franchi
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

My publications

128 publications

2016

Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study.

Circulation

PubMed • Publisher's site

2016

Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor: Results of the Prospective, Randomized SWAP-3 Study.

JACC. Cardiovascular interventions

PubMed • Publisher's site

2016

Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial.

Journal of the American College of Cardiology

PubMed • Publisher's site

2016

Switching P2Y12-receptor inhibitors in patients with coronary artery disease.

Nature reviews. Cardiology

PubMed • Publisher's site

2016

The Conundrum of Platelet P2Y12 Inhibition in ST-Segment Elevation Myocardial Infarction.

Circulation journal : official journal of the Japanese Circulation Society